(Q45399449)

English

Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.

scientific article published on 11 October 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Shigefumi Okamoto

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Hironori Yoshii

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Takami Akagi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Mitsuru Akashi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Toyokazu Ishikawa

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Yoshinobu Okuno

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Michiaki Takahashi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Koichi Yamanishi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Yasuko Mori

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

0 references

publication date

11 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

8270-8278

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Avian influenza A (H5N1) in 10 patients in Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Probable person-to-person transmission of avian influenza A (H5N1)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Vaccine adjuvants: current state and future trends

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Preparation and characterization of biodegradable nanoparticles based on poly(gamma-glutamic acid) with l-phenylalanine as a protein carrier.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(gamma-glutamic acid).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Multifunctional conjugation of proteins on/into bio-nanoparticles prepared by amphiphilic poly(gamma-glutamic acid).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

The Streptococcus pyogenes capsule is required for adhesion of bacteria to virus-infected alveolar epithelial cells and lethal bacterial-viral superinfection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal IgA production in response to the influenza virus antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

based on heuristic

inferred from DOI database lookup

Human CD4+ T-cell recognition of influenza A virus hemagglutinin after subunit vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.051

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.09.051

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17977633%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45399449&oldid=1382111572"